ONC201 is a first-in-class small molecule that antagonizes the G protein-coupled receptor (GPCR) and dopamine receptors D2 (DRD2) that causes p53-independent apoptosis in tumor cells via AKT/ERK inactivation [54]. Here, DRD2 is linked to neoplasm.